The Institute of Cancer Research is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
Applications for our main round of PhD recruitment are open. The deadline to apply is Sunday 14 November.
Men who inherit an increased risk of cancer through ‘Lynch syndrome’ could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer, researchers believe.
Her Royal Highness The Princess Royal has officially opened the Centre for Cancer Drug Discovery and toured the centre to learn more about its work to overcome cancer’s ability to evolve and become resistant to treatment.
We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
See what life is like as a student at The Institute of Cancer Research, the UK’s leading academic research centre.
We always want to hear from people who have a cancer story to share.
Get in touch and help raise awareness of our research.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
Clinical trial statistics: so much more than analysis
#BlackinCancer: Reaching communities most affected by prostate cancer
@behrens_lab @SudeepBhushal Welcome to the ICR! 👋
RT @Chemical_probes: There's still time to register for this symposium, including our Executive Director, @ICR_London's Professor Paul Work…
RT @denbogdan: Wonderful comment from Dr Jan Rekowski: "I am fond of languages and we all speak a different language depending on our backg…